Skip to main content

MetLife Investment Management, LLC's Form 4 filing

Neuberger High Yield Strategies Fund Inc. (NHS) · filed Jun 7, 2022

Accession no.
0001567619-22-012442
Filed
Jun 7, 2022
Trade date
Jun 3, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
MetLife Investment Management, LLCCIK 000152973510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 3, 2022Floating Rate Senior Note, Series B Note, Due Sep. 18, 2023PPurchaseAcquired+26,500,000$26,500,000.00F1+$702,250,000,000,000–IndirectPrice outlier

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This price reflects the aggregate principal amount of the Floating Rate Senior Note, Series B Note, due September 18, 2023 (the "Notes") purchased.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)